Welcome to the Whelan Lab!
We are a bioanalytical chemistry lab studying Ovarian Cancer.
Our Motivation:
The long-term survival statistics associated with ovarian cancer have remained unchanged for decades, and most ovarian cancer patients are diagnosed only after their disease has progressed to a metastatic stage. These cancer deaths are largely preventable: early detection of ovarian cancer correlates strongly with high rates of long-term survival. Early detection of ovarian cancer remains out of reach, however, in part because the existing tests for cancer-specific proteins (biomarkers) are insufficiently informative to be useful.
We view ovarian cancer as a human health problem in need of a measurement science solution. If we can identify alternative affinity probes—displaying more reliable detection of cancer-associated proteins—we can then use these probes as the basis of new tests for ovarian cancer.
Our Motivation:
The long-term survival statistics associated with ovarian cancer have remained unchanged for decades, and most ovarian cancer patients are diagnosed only after their disease has progressed to a metastatic stage. These cancer deaths are largely preventable: early detection of ovarian cancer correlates strongly with high rates of long-term survival. Early detection of ovarian cancer remains out of reach, however, in part because the existing tests for cancer-specific proteins (biomarkers) are insufficiently informative to be useful.
We view ovarian cancer as a human health problem in need of a measurement science solution. If we can identify alternative affinity probes—displaying more reliable detection of cancer-associated proteins—we can then use these probes as the basis of new tests for ovarian cancer.
April 2020 COVID-19 Social Distancing Group Photo
Announcements
Female-Led Research Teams Journal Issue
|
Lisa is Awarded a Fellowship! |
|
The Whelan lab is honored to be included in a special thematic issue of Analytical and Bioanalytical Chemistry highlighting Female Role Models in Analytical Chemistry. Take a look at the excellent analytical science being done in female-led research teams! Thank you to the organizers for inviting us to submit a contribution and congratulations to all the featured scientists. Check out the contributors here!
August 27, 2020 Sergio Welcomes a Fellowship!!
Congratulations are in order as Sergio joins the growing list of Whelan lab members with fellowships after being awarded the Rebecca Taiclet Hizer Memorial Fellowship! Way to go, Sergio!
August 11, 2020 |
Lisa was selected to receive a 2020-2021 Berry Family Foundation Fellowship. Awarded through Notre Dame Advanced Diagnostics & Therapeutics, this fellowship will fully support Lisa's graduate training for one calendar year. Lisa's proposed project was "Exploring the Utility of Polyclonal Aptamers for Early Stage Ovarian Cancer Detection."
June 9, 2020 And the CBBI Fellowship goes to... Naviya!
Naviya Schuster-Little has been selected as a 2020 Chemistry-Biochemistry-Biology Interface (CBBI) fellow. This NIH-funded training grant will support Naviya for her work in proteomics and aptamer selection, including intensive training in the lab of our collaborator Manish Patankar in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine. Congratulations, Naviya!!
April 8, 2020 |
The Whelan Lab is premier research group in the world class facility of McCourtney Hall.
- Susan Skube
|
Whelan Lab Funding -Center for Bioanalytic Metrology (an NSF-IUCRC) -T.E.A.L. Foundation -Advanced Diagnostics & Therapeutics -Indiana CTSI Disease Diagnostics Inventors Challenge -Walther Cancer Foundation (to Nicole) -CBBI (to Naviya) -Berry Family Foundation Fellowship (to Lisa) -Rebecca Taiclet Hizer Memorial Fellowship(to Sergio) |
|
